| Issue |
Section |
Title |
File |
| Vol 90, No 1 (2014) |
ORIGINAL STUDIES |
Level of the proliferative activity of lymphocytes in case of mycosis fungoides and plaque parapsoriasis |
(Rus)
|
| Vol 90, No 1 (2014) |
DRUG TREATMENT IN DERMATOVENEROLOGY |
Application of external drugs comprising silver compounds for the treatment of pyodermic patients |
(Rus)
|
| Vol 90, No 3 (2014) |
DRUG TREATMENT IN DERMATOVENEROLOGY |
Clinical experience of using metronidazole as an external therapy of acne |
(Rus)
|
| Vol 90, No 4 (2014) |
CLINICAL CASE REPORTS |
Clinical and morphological features of elastolytic granulomas |
(Rus)
|
| Vol 90, No 5 (2014) |
DRUG TREATMENT IN DERMATOVENEROLOGY |
Experience use of azelaic acid in patients with acne |
(Rus)
|
| Vol 91, No 5 (2015) |
Articles |
Cutaneous lupus erythematosus: pathogenesis, clinical pattern, diagnostics, therapy |
(Rus)
|
| Vol 91, No 6 (2015) |
ORIGINAL STUDIES |
Pathomorphological changes in patients with Jessner>s lymphocytic infiltrate of skin, reticular erythematous mucinosis and lupus tumidus |
(Rus)
|
| Vol 92, No 1 (2016) |
SHORT COMMUNICATION |
Modern concepts of skin dendritic cells |
(Rus)
|
| Vol 92, No 4 (2016) |
SHORT COMMUNICATION |
Immune pathogenesis of psoriasis |
(Rus)
|
| Vol 92, No 4 (2016) |
DRUG TREATMENT IN DERMATOVENEROLOGY |
Topical formulations used in the treatment of acne |
(Rus)
|
| Vol 93, No 5 (2017) |
ORIGINAL STUDIES |
Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhibitor. Results of Phase II Clinical Trial in Patients with Moderate-to-Severe Plaque Psoriasis |
(Rus)
|
| Vol 94, No 2 (2018) |
DRUG TREATMENT IN DERMATOVENEROLOGY |
ETIOPATHOGENETIC THERAPY OF INFLAMMATORY DERMATOSES |
(Rus)
|
| Vol 94, No 4 (2018) |
DRUG TREATMENT IN DERMATOVENEROLOGY |
Features of treatment of patients with psoriasis with metabolic syndrome |
(Rus)
|
| Vol 94, No 6 (2018) |
SHORT COMMUNICATION |
Psoriatic onychodystrophy: clinical manifestations (part 1) |
(Rus)
|
| Vol 95, No 1 (2019) |
REVIEWS |
Psoriatic onychodystrophy: indices for assessing the severity of psoriatic onychodystrophy (part 2) |
(Rus)
|
| Vol 95, No 2 (2019) |
REVIEWS |
Clinical and pathological changes in the skin with granuloma annulare |
(Rus)
|
| Vol 95, No 2 (2019) |
ORIGINAL STUDIES |
Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis |
(Rus)
|
| Vol 95, No 3 (2019) |
DRUG TREATMENT IN DERMATOVENEROLOGY |
Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext |
(Rus)
|
| Vol 95, No 4 (2019) |
ORIGINAL STUDIES |
Studying of the interleukin-36γ expression level in the skin of patients with plaque psoriasis |
(Rus)
|
| Vol 95, No 5 (2019) |
ORIGINAL STUDIES |
Distribution of melanocytes in the skin of psoriasis patients |
(Rus)
|
| Vol 95, No 6 (2019) |
REVIEWS |
Precision therapy for psoriasis patients |
(Rus)
|
| Vol 97, No 5 (2021) |
REVIEWS |
Revisiting the question of psoriasis classification |
(Rus)
|
